These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1032 related items for PubMed ID: 28841223

  • 1. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS, Zhang Q, Sada YH, Chai C, Curley SA, Massarweh NN.
    Cancer; 2018 Jan 01; 124(1):74-83. PubMed ID: 28841223
    [Abstract] [Full Text] [Related]

  • 2. Outcome of adjuvant therapy in biliary tract cancers.
    McNamara MG, Walter T, Horgan AM, Amir E, Cleary S, McKeever EL, Min T, Wallace E, Hedley D, Krzyzanowska M, Moore M, Gallinger S, Greig P, Serra S, Dawson LA, Knox JJ.
    Am J Clin Oncol; 2015 Aug 01; 38(4):382-7. PubMed ID: 24572429
    [Abstract] [Full Text] [Related]

  • 3. Systemic adjuvant chemotherapy for cholangiocarcinoma surgery: A systematic review and meta-analysis.
    Rangarajan K, Simmons G, Manas D, Malik H, Hamady ZZ.
    Eur J Surg Oncol; 2020 Apr 01; 46(4 Pt A):684-693. PubMed ID: 31761507
    [Abstract] [Full Text] [Related]

  • 4. Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins.
    Glazer ES, Liu P, Abdalla EK, Vauthey JN, Curley SA.
    J Gastrointest Surg; 2012 Sep 01; 16(9):1666-71. PubMed ID: 22777053
    [Abstract] [Full Text] [Related]

  • 5. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
    Kim YS, Hwang IG, Park SE, Go SI, Kang JH, Park I, Oh SY, Ji JH, Song HN, Park SH, Kim ST, Park JO.
    Cancer Chemother Pharmacol; 2016 May 01; 77(5):979-85. PubMed ID: 27017615
    [Abstract] [Full Text] [Related]

  • 6. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T, Qin LX, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Tang ZY, Fan J.
    Liver Int; 2014 Jul 01; 34(6):953-60. PubMed ID: 24134199
    [Abstract] [Full Text] [Related]

  • 7. The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas.
    Kim YS, Oh SY, Go SI, Kang JH, Park I, Song HN, Ji JH, Hwang IG, Jang JS.
    Cancer Chemother Pharmacol; 2017 Jan 01; 79(1):99-106. PubMed ID: 27928598
    [Abstract] [Full Text] [Related]

  • 8. Association of Liver-Directed Local Therapy With Overall Survival in Adults With Metastatic Intrahepatic Cholangiocarcinoma.
    Sebastian NT, Tan Y, Miller ED, Williams TM, Noonan AM, Hays JL, Abdel-Misih S, Diaz DA.
    JAMA Netw Open; 2019 Sep 04; 2(9):e1911154. PubMed ID: 31517963
    [Abstract] [Full Text] [Related]

  • 9. Adjuvant Chemotherapy and Radiation Therapy is Associated with Improved Survival for Patients with Extrahepatic Cholangiocarcinoma.
    Hoehn RS, Wima K, Ertel AE, Meier A, Ahmad SA, Shah SA, Abbott DE.
    Ann Surg Oncol; 2015 Dec 04; 22 Suppl 3():S1133-9. PubMed ID: 25976862
    [Abstract] [Full Text] [Related]

  • 10. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, Wang BL, Li D, Wang JH, Zeng MS, Guo W, Tan YS.
    Cancer J; 2006 Dec 04; 12(2):113-22. PubMed ID: 16630402
    [Abstract] [Full Text] [Related]

  • 11. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.
    Scheuermann U, Kaths JM, Heise M, Pitton MB, Weinmann A, Hoppe-Lotichius M, Otto G.
    Eur J Surg Oncol; 2013 Jun 04; 39(6):593-600. PubMed ID: 23611755
    [Abstract] [Full Text] [Related]

  • 12. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
    Ecker BL, Vining CC, Roses RE, Maggino L, Lee MK, Drebin JA, Fraker DL, Vollmer CM, Datta J.
    Ann Surg Oncol; 2017 Dec 04; 24(13):3926-3933. PubMed ID: 28952140
    [Abstract] [Full Text] [Related]

  • 13. Failure to administer multimodality therapy leads to sub-optimal outcomes for patients with node-positive biliary tract cancers in the United States.
    Sheka AC, Altman A, Marmor S, Hui JYC, Denbo JW, Ankeny JS, Jensen EH.
    Surg Oncol; 2020 Sep 04; 34():298-303. PubMed ID: 32891346
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H, Cornillet M, Björkström NK, Sturesson C, Sparrelid E.
    Eur J Surg Oncol; 2020 May 04; 46(5):804-810. PubMed ID: 31848078
    [Abstract] [Full Text] [Related]

  • 15. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
    Song S, Kim K, Chie EK, Kim S, Park HJ, Yi NJ, Suh KS, Ha SW.
    Clin Transl Oncol; 2015 Oct 04; 17(10):825-9. PubMed ID: 26041722
    [Abstract] [Full Text] [Related]

  • 16. Adjuvant radiotherapy improves long-term survival after resection for gallbladder cancer A population-based cohort study.
    Kamarajah SK, Al-Rawashdeh W, White SA, Abu Hilal M, Salti GI, Dahdaleh FS.
    Eur J Surg Oncol; 2022 Feb 04; 48(2):425-434. PubMed ID: 34518052
    [Abstract] [Full Text] [Related]

  • 17. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer.
    Matull WR, Dhar DK, Ayaru L, Sandanayake NS, Chapman MH, Dias A, Bridgewater J, Webster GJ, Bong JJ, Davidson BR, Pereira SP.
    Liver Int; 2011 Jan 04; 31(1):99-107. PubMed ID: 20846273
    [Abstract] [Full Text] [Related]

  • 18. Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
    Gholami S, Colby S, Horowitz DP, Guthrie KA, Ben-Josef E, El-Khoueiry AB, Blanke CD, Philip PA, Kachnic LA, Ahmad SA, Rocha FG.
    Ann Surg Oncol; 2023 Mar 04; 30(3):1354-1363. PubMed ID: 36622529
    [Abstract] [Full Text] [Related]

  • 19. Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma.
    Geng ZM, Cai ZQ, Zhang Z, Tang ZH, Xue F, Chen C, Zhang D, Li Q, Zhang R, Li WZ, Wang L, Si SB.
    World J Gastroenterol; 2019 Oct 07; 25(37):5655-5666. PubMed ID: 31602165
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.